Sotera Health (SHC) Company announced the launch of a secondary offering of 30M shares of its common stock. All 30M shares are being offered for sale by certain affiliates of Warburg Pincus and GTCR as selling stockholders. No other entities, and no individuals, are selling shares in the offering. The company is not offering any shares in the offering and will not receive any of the proceeds from the offering. Goldman Sachs & Co. is acting as the underwriter for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Sotera Health price target raised to $17 from $15 at Piper Sandler
- Sotera Health price target raised to $16 from $14 at JPMorgan
- Sotera Health price target raised to $20 from $19 at Barclays
- Sotera Health Reports Strong Q3 2025 Financial Results
- Sotera Health Earnings Call: Strong Growth Amid Challenges